Background: Intimate Partner violence (IPV) is one of the common forms of violence against women and is a global public health problem that transcends social, economic, religious and cultural groups. It is often perceived as a private problem or a normal part of life but it contributes greatly to morbidity and mortality.
Objective: To assess the prevalence and correlates of intimate partner violence by male civil servants in Oyo State Secretariat Ibadan, Nigeria.
Methods: A cross-sectional study was conducted using a multi-stage sampling technique. A total of 609 respondents completed a pre-tested self-administered questionnaire. Data were analysed using SPSS version 18 and STATA version 12. Chi-square statistic was used to test associations between categorical variables and predictors of perpetration of intimate partner violence were determined using logistic regression model at a level of statistical significance of 5%.
Result: The mean age was 38.8±9.9 years and about 74.5% were married. The prevalence of IPV perpetration in the 12 months preceding the study was 66.0%. The prevalence of controlling behaviour was 52.2%, psychological abuse - 31.2%, sexual violence - 23.0%, and physical violence - 11.7%. The predictors of perpetrating any form of IPV included previous history of physical fight with another woman [OR: 2.4 (95% CI: 1.30-3.40)], having a negative attitude towards wife beating [OR 2.5 [95% CI: 1.85-3.42], childhood exposure to parental IPV [OR: 2.1 (95% CI: 1.30-3.41)] and use of alcohol [OR: 1.6 (95% CI: 1.14-2.15].
Conclusion: The different types of IPV were prevalent among the male civil servants, despite their educational status. Strategies to stop IPV should include male education to change attitudes that encourage violence in relationships to use of non-violent conflict resolution strategies. Education should also include the dangers of alcohol abuse and involvement in physical fights.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679182 | PMC |
Epidemiol Serv Saude
January 2025
Universidade Federal de Goiás, Instituto de Patologia Tropical e Saúde Pública, Departamento de Saúde Coletiva, Goiânia, GO, Brasil.
Objective: To identify social vulnerability profiles of transgender people who have experienced intimate partner violence in Brazil and to assess the association with recurrent violence and referrals to support services.
Methods: This was a cross-sectional study of reported cases of violence against transgender people in Brazil (2015-2021) utilizing data from SINAN/DATASUS. Sociodemographic profiles were defined using two-step cluster analysis and associations estimated by means of binary logistic regression, with odds ratios (OR) and confidence intervals (CI).
PLoS One
January 2025
Center for Gender Equity and Health, University of California, San Diego, California, United States of America.
Objectives: To assess the association between gender equality beliefs and self-reported intimate partner violence (IPV) perpetration among California men.
Methods: We analyzed men's data (N = 3609) from three waves (2021, 2022, and 2023) of cross-sectional data from a statewide sample of California adults. We assessed gender equality beliefs using a three-item measure adapted from the World Values Survey, with higher scores representing more gender unequal beliefs (e.
Prev Med Rep
January 2025
Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.
Objective: Assess the association between having witnessed physical violence between parents and intimate partner violence (IPV) against men in Bolivian adults according to the Encuesta de Demografia y Salud (EDSA) 2016.
Methods: A retrospective cross-sectional study was conducted using data from the EDSA 2016 in Bolivia. The variable of interest in this study was IPV in men experienced during the last 12 months (any type of violence, physical and/or sexual, and psychological).
Mol Genet Metab Rep
March 2025
Alnylam Pharmaceuticals, Maidenhead, UK.
Background: Acute hepatic porphyria (AHP) is characterized by debilitating and potentially life-threatening neurovisceral attacks, possible chronic symptoms, and long-term complications. In a phase 1/2 open-label extension (OLE) study and the phase 3 ENVISION study, givosiran led to sustained improvement in annualized attack rate and quality of life (QOL) measures. To capture the patient experience of symptoms and impacts of AHP, and any changes experienced during treatment with givosiran, qualitative interviews were conducted with study participants.
View Article and Find Full Text PDFBr J Psychiatry
January 2025
Department of Scientific Research, The Second Affiliated Hospital of Anhui Medical University, Hefei, China; and Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Anhui, China.
Background: Depressive disorders pose a significant global public health challenge, yet evidence on their burden remains insufficient.
Aims: To report the global, regional and national burden of depressive disorders and their attributable risk factors from 1990 to 2021.
Methods: Data from the Global Burden of Disease 2021 were analyzed for 204 countries and territories from 1990 to 2021.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!